About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Addressing Unmet Needs for Cholangiocarcinoma & Myeloid Lymphoid Neoplasms
Addressing Unmet Needs for Cholangiocarcinoma & Myeloid Lymphoid Neoplasms
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
P
Managing Treatment-Related Side Effects in GI Cancers: Chemo, Targeted Therapy, and IO
By
2023 Johns Hopkins Updates in Gastrointestinal Cancers
FEATURING
Paige Griffith
By
2023 Johns Hopkins Updates in Gastrointestinal Cancers
FEATURING
Paige Griffith
213 views
March 7, 2023
0 Comments
Login to view comments.
Click here to Login
Addressing Unmet Needs for Cholangiocarcinoma & Myeloid Lymphoid Neoplasms
10:43
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Clas…
Feat.
A. Vogel
03:49
ecancer
ASCO® 2023 Insights: "IMbrave050 Data on Atezolizumab + Bevaciz…
Feat.
M. Kudo
02:22
ecancer
ASCO® 2023 Insights: "ATTRACTION-5 Study on Nivo + Chemo as Pos…
Feat.
M. Terashima
05:46
Penn Medicine Abramson Cancer Center
Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…
Feat.
T. Karasic
12:04
Arndt Vogel
Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions
09:06
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…
Feat.
T. Karasic
30:00
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Managing Treatment-Related Side Effects in GI Cancers: Chemo, Target…
Feat.
P. Griffith
23:37
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in BTC
Feat.
M. Baretti
27:37
Indy Hematology Review
Review of Myeloproliferative Neoplasms
Feat.
A. Tefferi
06:22
Milind Javle
Importance of Molecular Profiling in Biliary Tract Cancer
08:24
ASH 2022 Conference Coverage
Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Ne…
Feat.
A. Vannucchi
08:15
Prithviraj Bose
Myeloid/Lymphoid Neoplasms With Fusion Tyrosine Kinase Genes: Treatm…
05:32
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Phase 3 Randomized SWOG 1815 Trial: Gemcitabine, Cispla…
Feat.
R. Shroff
06:55
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Evaluation of Clinical Benefit and PFS Ratio of Targete…
Feat.
M. Niger
11:09
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Novel Therapies for Eosinophilia
Feat.
E. Hexner
17:35
Lorenza Rimassa
Targeted Therapies for Cholangiocarcinoma
38:33
MedNews Week
Cholangiocarcinoma: Disease Overview, Diagnosis, and Treatment Optio…
Feat.
J. Cleary
15:42
Richard Kim
Treatment Algorithm Series: Management of Advanced Cholangiocarcinoma
Feat.
A. Mahipal
